I maggiori titoli Taiwanese (TAIEX) Pharmaceuticals & Biotech per capitalizzazione di mercato

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

AGGIORNATO Aug 23, 2026

Scopri le società large cap Taiwanese Pharmaceuticals & Biotech che si trovano sul TAIEX. Queste Pharmaceuticals & Biotech Companies sono organizzate per capitalizzazione di mercato.

145 aziende

Azienda	Ultimo prezzo	Ritorno 7D	Ritorno a 1 anno	Cap. di mercato	Obiettivo degli analisti	Valutazione	Crescita	Rendimento del dividendo
6446	NT$1,400.00	-6.7%	251.4%	NT$580.2b	NT$1,312.17	76.1	52.2%	0.07%
6919	NT$113.50	9.1%	-40.3%	NT$176.5b	NT$240.00	6006.1	136.5%	n/a
6696	NT$939.00	3.0%	509.7%	NT$77.8b	n/a	7.3	n/a	n/a
6949	NT$1,155.00	7.9%	195.4%	NT$74.8b	n/a	2586.9	n/a	n/a
6472	NT$455.00	11.2%	-39.0%	NT$57.9b	NT$579.04	31.9	46.0%	2.2%
1795	NT$196.50	8.9%	1.3%	NT$52.3b	NT$319.50	13.9	39.5%	1.3%
7924	NT$274.00	-0.7%	n/a	NT$36.6b	n/a	409.2	n/a	n/a
4123	NT$32.95	0.9%	-6.4%	NT$25.8b	n/a	25.3	n/a	5.0%
4743	NT$50.00	6.6%	-32.4%	NT$24.0b	NT$308.00	394.1	n/a	0%
6586	NT$111.50	-1.3%	175.3%	NT$23.9b	n/a	13995.4	n/a	n/a
4728	NT$395.50	2.6%	-4.0%	NT$21.5b	n/a	29.8	n/a	3.1%
7827	NT$161.00	0%	94.9%	NT$21.0b	n/a	67.1	n/a	n/a
4105	NT$78.40	3.0%	2.6%	NT$19.5b	NT$92.00	11.2	n/a	5.7%
7871	NT$141.00	22.6%	n/a	NT$18.9b	n/a	167.0	n/a	n/a
6547	NT$55.70	8.2%	42.5%	NT$18.3b	NT$102.00	31.9	163.7%	n/a
4147	NT$63.10	-1.7%	-20.4%	NT$17.2b	NT$180.00	27.8	-46.8%	n/a
4114	NT$30.55	2.5%	-7.1%	NT$16.5b	n/a	19.9	n/a	2.6%
6589	NT$50.50	3.7%	-17.9%	NT$15.5b	NT$111.00	12.6	128.2%	n/a
6712	NT$151.50	3.1%	3.6%	NT$15.4b	NT$152.38	32.6	6.4%	2.2%
1789	NT$19.15	0.8%	6.7%	NT$15.4b	n/a	401.4	n/a	1.5%
3705	NT$55.70	2.6%	-0.9%	NT$14.8b	n/a	16.6	n/a	5.4%
6535	NT$80.90	-6.0%	-58.9%	NT$13.5b	n/a	394.3	n/a	n/a
6617	NT$107.50	9.1%	5.9%	NT$13.0b	n/a	340.4	n/a	n/a
6748	NT$179.00	2.3%	117.0%	NT$12.7b	n/a	241.6	n/a	n/a

Azienda	Ultimo prezzo	Ritorno 7D	Ritorno a 1 anno	Cap. di mercato	Obiettivo degli analisti	Valutazione	Crescita	Rendimento del dividendo
6446	NT$1,400.00	-6.7%	251.4%	NT$580.2b	NT$1,312.17	76.1	52.2%	0.07%
6919	NT$113.50	9.1%	-40.3%	NT$176.5b	NT$240.00	6006.1	136.5%	n/a
6696	NT$939.00	3.0%	509.7%	NT$77.8b	n/a	7.3	n/a	n/a
6949	NT$1,155.00	7.9%	195.4%	NT$74.8b	n/a	2586.9	n/a	n/a
6472	NT$455.00	11.2%	-39.0%	NT$57.9b	NT$579.04	31.9	46.0%	2.2%
1795	NT$196.50	8.9%	1.3%	NT$52.3b	NT$319.50	13.9	39.5%	1.3%
7924	NT$274.00	-0.7%	n/a	NT$36.6b	n/a	409.2	n/a	n/a
4123	NT$32.95	0.9%	-6.4%	NT$25.8b	n/a	25.3	n/a	5.0%
4743	NT$50.00	6.6%	-32.4%	NT$24.0b	NT$308.00	394.1	n/a	0%
6586	NT$111.50	-1.3%	175.3%	NT$23.9b	n/a	13995.4	n/a	n/a
4728	NT$395.50	2.6%	-4.0%	NT$21.5b	n/a	29.8	n/a	3.1%
7827	NT$161.00	0%	94.9%	NT$21.0b	n/a	67.1	n/a	n/a
4105	NT$78.40	3.0%	2.6%	NT$19.5b	NT$92.00	11.2	n/a	5.7%
7871	NT$141.00	22.6%	n/a	NT$18.9b	n/a	167.0	n/a	n/a
6547	NT$55.70	8.2%	42.5%	NT$18.3b	NT$102.00	31.9	163.7%	n/a
4147	NT$63.10	-1.7%	-20.4%	NT$17.2b	NT$180.00	27.8	-46.8%	n/a
4114	NT$30.55	2.5%	-7.1%	NT$16.5b	n/a	19.9	n/a	2.6%
6589	NT$50.50	3.7%	-17.9%	NT$15.5b	NT$111.00	12.6	128.2%	n/a
6712	NT$151.50	3.1%	3.6%	NT$15.4b	NT$152.38	32.6	6.4%	2.2%
1789	NT$19.15	0.8%	6.7%	NT$15.4b	n/a	401.4	n/a	1.5%
3705	NT$55.70	2.6%	-0.9%	NT$14.8b	n/a	16.6	n/a	5.4%
6535	NT$80.90	-6.0%	-58.9%	NT$13.5b	n/a	394.3	n/a	n/a
6617	NT$107.50	9.1%	5.9%	NT$13.0b	n/a	340.4	n/a	n/a
6748	NT$179.00	2.3%	117.0%	NT$12.7b	n/a	241.6	n/a	n/a